Standout Papers

Abelacimab for Prevention of Venous Thromboembolism 2021 2026 2022 2024165
  1. Abelacimab for Prevention of Venous Thromboembolism (2021)
    Peter Verhamme, B. Alexander Yi et al. New England Journal of Medicine
  2. Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation (2025)
    Christian T. Ruff, Siddharth M. Patel et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 10 from Science/Nature 61 standout
Sub-graph 1 of 20

Citing Papers

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure
2024 Standout
Blinded, randomized trial of sonographer versus AI cardiac function assessment
2023 StandoutNature
11 intermediate papers

Works of Daniel M. Bloomfield being referenced

Microvolt T-Wave Alternans Distinguishes Between Patients Likely and Patients Not Likely to Benefit From Implanted Cardiac Defibrillator Therapy
2004
Autonomic nervous system influences on qt interval in normal subjects
2002
and 6 more

Author Peers

Author Last Decade Papers Cites
Daniel M. Bloomfield 3886 877 758 97 5.1k
Savina Nodari 3925 870 653 189 5.3k
Hamid Ikram 4388 780 956 186 5.7k
Livio Dei 4291 926 988 203 5.8k
Kenneth Dickstein 5514 848 862 104 6.9k
David E. Johnstone 4478 833 699 90 5.8k
Filippos Triposkiadis 3609 710 694 212 5.2k
Ayan R. Patel 3082 1238 702 116 4.8k
Mona Fiuzat 5149 769 1262 181 6.8k
Naoki Sato 3670 753 1060 218 5.3k
Andrew P. Ambrosy 4765 829 1178 193 6.0k

All Works

Loading papers...

Rankless by CCL
2026